Suchergebnisse - "Plummer, Ruth"

PubPharm (233)

1

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery : a multicenter, retrospective cohort study

enthalten in: EClinicalMedicine | 2024

von Bai, X. | Shaheen, A. | Grieco, C. | +43

ErratumFor: EClinicalMedicine. 2023 Oct 31;65:102290. - PMID 37965433

2

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Sacco, J. | Jackson, R. | Corrie, P. | +18

3

Nilotinib in KIT-driven advanced melanoma : Results from the phase II single-arm NICAM trial

enthalten in: Cell reports. Medicine | 2024

von Larkin, J. | Marais, R. | Porta, N. | +20

4

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis : the EASI-SWITCH RCT

enthalten in: Health technology assessment (Winchester, England) | 2024

von Coyle, V. | Forde, C. | Adams, R. | +14

5

Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer : A Quantitative Synthesis and Meta-analysis

enthalten in: European urology oncology | 2024

von Messina, C. | Giunta, E. | Signori, A. | +11

6

First-in-Human Study of the Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Yap, T. | Tolcher, A. | Plummer, R. | +8

7

Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Rosen, E. | Yap, T. | Lee, E. | +11

8

Histology independent drug development - Is this the future for cancer drugs?

enthalten in: Cancer treatment reviews | 2024

von Billingham, L. | Brown, L. | Framke, T. | +10

9

Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH) : a randomized non-inferiority trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Coyle, V. | Forde, C. | McAuley, D. | +14

10

Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer : A Phase II Multi-Cohort Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Drew, Y. | Kim, J. | Penson, R. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]